Voya Investment Management Llc Tilts From Mega-Cap AI To Defensives

The biggest buys cluster around three ideas: own the AI pick‑and‑shovel suppliers, lock in pharma cashflows, and lean into scale retail and media platforms with real pricing power.

On the semis side, Voya stops just owning the headline GPU winners and leans into the equipment layer. The jump in Applied Materials (AMAT) by +274.4% ($468.4M) and a 22.0% add to ASML signal a view that wafer‑fab capex will prove more durable than sentiment, while increases in Monolithic Power (MPWR) and Vertiv (VRT) extend that bet into power management and data‑center infrastructure.

Health care is the other clear winner. Johnson & Johnson (JNJ) is lifted by +308.0% (about $678.5M of added value) and Merck (MRK) by +72.7% (roughly $261.3M), indicating a preference for diversified pharma with broad pipelines rather than a single GLP‑1 hero. Gilead (GILD) is also quietly increased by 11.1%, rounding out the defensive drug basket.

Consumer exposure shifts toward scale and subscription. Costco (COST) explodes +542.3% (about $578.8M), and Netflix (NFLX) is up +391.7% (roughly $409.7M), framing a thesis that membership models and global distribution trump cyclical worries. Coca‑Cola (KO) is boosted +23.4%, reinforcing the desire for steady, brand‑driven cashflows at the core of the book.

There is also a notable new line in Oracle (ORCLPRD) at about $407.2M and a big add to Akamai (AKAM) (+244.9%, ~$356.0M). Together with larger stakes in Cloudflare (NET), Palantir (PLTR), and Coherent (COHR), that points to an ongoing appetite for data, security, and network infrastructure that underpins cloud and AI workloads.

The funding side of the ledger is blunt: sell down the most crowded winners and trim macro‑sensitive cyclicals. Microsoft (MSFT) is cut by -29.9%, freeing up an estimated $1.08B; this isn’t a repudiation of AI, but a recognition that the easy multiple expansion is likely behind it.

Lam Research (LRCX) takes a -26.2% hit (about $301.6M trimmed) even as other semicap names are increased, suggesting name‑specific risk management rather than a broad equipment de‑risk. Alphabet’s non‑voting line (GOOG) is down -33.7% (~$291.2M), while the voting GOOGL line is actually increased, implying a preference for governance optionality as they right‑size exposure.

Macro beta is also coming down. Wells Fargo (WFC) is slashed -41.9% (roughly $293.3M), and Cisco (CSCO) drops -36.3% ($290.5M), in line with cooling enthusiasm for rate‑sensitive banks and legacy networking hardware. Eli Lilly (LLY) is trimmed -22.3% ($299.8M) despite strong gains vs cost, likely reflecting a desire to rotate from the most crowded GLP‑1 trade into cheaper, more diversified pharma like JNJ and MRK.

Around the edges, they chip away at Microsoft‑adjacent and index‑like tech: small cuts to Broadcom (AVGO), Taiwan Semi (TSM), and Apple’s peers despite keeping Nvidia (NVDA) almost flat. That pattern says: crystallize profits where valuation has run furthest, hold onto the core AI silicon leader, and recycle capital into under‑owned parts of the same ecosystem.

The sector chart shows a deliberate softening at the tech apex, not a wholesale retreat. Technology slips from 62.16% to 58.1%, but that four‑point give‑up is more about de‑crowding MSFT, CSCO, and a slice of Alphabet than abandoning the theme; semis and infrastructure still dominate the tech sleeve.

The beneficiaries are the classic defensives and hard‑asset cashflow stories. Health care climbs from 5.04% to 6.3% on the back of JNJ, MRK, and Gilead, giving the portfolio a steadier earnings base. Energy jumps from 0.62% to 1.19% via a near doubling of Exxon (XOM), and consumer staples rise from 1.12% to 1.33% as KO grows, adding commodity and pricing‑power ballast.

Consumer discretionary morphs rather than shrinks: its weight increases from 6.47% to 8.18%, but away from basic retail toward Costco and Netflix scale economics. Industrials inch up to 8.06% from 7.94% as Parker‑Hannifin (PH), RTX, Cummins (CMI), and GE Vernova (GEV) see adds, indicating a conviction that industrial automation, defense, and grid upgrades will accompany AI‑driven capex.

Finance, by contrast, bleeds from 3.5% to 3.14% despite a near 19.8% bump in JPMorgan (JPM), thanks to the heavy WFC trim. Telecommunications (really a proxy for Cisco) falls sharply from 1.75% to 1.07%, underlining the view that legacy networking has less upside than newer cloud and edge names.

Taken together, these moves describe a manager that still wants upside from AI and digital infrastructure, but is no longer willing to ride that bet naked. The portfolio is evolving into a barbell: semis, cloud infrastructure, and data‑driven software on one side; big pharma, staples, and energy on the other.

The decisive adds to JNJ, MRK, COST, KO, and XOM suggest an expectation of more volatile macro and policy conditions, where reliable free‑cash‑flow and dividends matter as much as top‑line growth. At the same time, the rotation within tech — out of mega‑cap platforms and into AMAT, ASML, MPWR, VRT, NET, PLTR, Akamai, and Oracle — implies the thesis that AI’s next leg of value creation will accrue to the tools, infrastructure, and data layers rather than just the headline consumer apps.

Trims in WFC and CSCO, plus the modest cooling in Microsoft and a slice of Alphabet, read as risk‑budget management: dial down rate and regulatory risk, plus the most consensus AI plays, to keep dry powder for dislocations. The three‑ and five‑year performance record suggests this is being done from a position of strength, not capitulation.

For observers, the signal is clear: Voya is not chasing an AI bubble; it is methodically tilting toward the parts of the stack and the sectors that can compound through different macro regimes. The next few quarters will show whether this more resilient construction can keep delivering equity‑like upside with far less reliance on a narrow set of tech champions.